Natco Pharma Promoter Pledges 0.47% Stake for Rights Issue
Natco Pharma Ltd · Encumbered Shares - Invocation / Release · 04 Nov 2026, 9:01 pm
Natco Pharma Promoter Pledges 0.47% Stake for Rights Issue Natco Pharma promoter V.C. Nannapaneni created a pledge on 8,50,000 equity shares (face value ₹2 each), representing 0.47% of the total share capital, on 9th Oct'26 in favor of Bajaj Financial Securities Limited. The pledge was executed to fund participation in the company's rights issue. Prior to this event, Nannapaneni held 2,80,45,905 shares (15.66% stake) with zero encumbrances. Post-transaction, total encumbered holding stands at 8,50,000 shares (0.47% of total capital), as per revised disclosures submitted on 4th Nov'26.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Intimation of Investor Meet · 17 Nov 2026
- Audio link of Earnings Conference Call Q2FY27 · 14 Nov 2026
- Q2 FY27 Earnings Presentation · 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 · 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Outcome of Board Meeting · 13 Nov 2026
- Intimation of schedule of Concall · 13 Nov 2026
